[{"address1": "10900 NE 4th Street", "address2": "Suite 2300", "city": "Bellevue", "state": "WA", "zip": "98004", "country": "United States", "phone": "425 635 7700", "website": "https://www.bellevuespac.com", "industry": "Shell Companies", "industryKey": "shell-companies", "industryDisp": "Shell Companies", "sector": "Financial Services", "sectorKey": "financial-services", "sectorDisp": "Financial Services", "longBusinessSummary": "Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Kuk Hyoun Hwang", "age": 47, "title": "CEO & Director", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Jin Yoo", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 10.95, "open": 10.96, "dayLow": 10.95, "dayHigh": 10.96, "regularMarketPreviousClose": 10.95, "regularMarketOpen": 10.96, "regularMarketDayLow": 10.95, "regularMarketDayHigh": 10.96, "volume": 202, "regularMarketVolume": 202, "averageVolume": 317, "averageVolume10days": 330, "averageDailyVolume10Day": 330, "bid": 9.41, "ask": 13.75, "bidSize": 100, "askSize": 100, "fiftyTwoWeekLow": 10.085, "fiftyTwoWeekHigh": 12.0, "fiftyDayAverage": 10.9824, "twoHundredDayAverage": 10.972575, "currency": "USD", "enterpriseValue": 45727252, "floatShares": 1374662, "sharesShort": 1, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "heldPercentInsiders": 0.17729001, "heldPercentInstitutions": 0.03635, "shortRatio": 0.01, "bookValue": -1.213, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -165714, "52WeekChange": 0.034971595, "SandP52WeekChange": 0.24014747, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BLACU", "underlyingSymbol": "BLACU", "shortName": "Bellevue Life Sciences Acquisit", "longName": "Bellevue Life Sciences Acquisition Corp.", "firstTradeDateEpochUtc": 1676039400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c03266e9-febf-33f0-8861-881a1ccd56fb", "messageBoardId": "finmb_1780296556", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.95, "recommendationKey": "none", "totalCash": 119116, "totalCashPerShare": 0.029, "totalDebt": 1595000, "quickRatio": 0.035, "currentRatio": 0.049, "returnOnAssets": -0.029830001, "freeCashflow": -65316, "operatingCashflow": -1880879, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]